Kabra Drugs Ltd vs Mercury Laboratories Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 09, 2026

Key Highlights

The Latest Trading Price of Kabra Drugs Ltd is ₹ 26.85 as of 08 May 15:30 . The P/E Ratio of Kabra Drugs Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe P/E Ratio of Mercury Laboratories Ltd changed from 14.4 on March 2021 to 31.3 on March 2025 . This represents a CAGR of 16.80% over 5 years The Market Cap of Kabra Drugs Ltd changed from ₹ 2 crore on March 2022 to ₹ 26.27 crore on March 2025 . This represents a CAGR of 90.37% over 4 yearsThe Market Cap of Mercury Laboratories Ltd changed from ₹ 77.11 crore on March 2021 to ₹ 98.29 crore on March 2025 . This represents a CAGR of 4.97% over 5 years The revenue of Kabra Drugs Ltd for the Dec '25 is ₹ 30.6 crore as compare to the Sep '25 revenue of ₹ 19.94 crore. This represent the growth of 53.46% The revenue of Mercury Laboratories Ltd for the Dec '25 is ₹ 18.66 crore as compare to the Sep '25 revenue of ₹ 19.8 crore. This represent the decline of -5.76% The ebitda of Kabra Drugs Ltd for the Dec '25 is ₹ 2.62 crore as compare to the Sep '25 ebitda of ₹ 2.22 crore. This represent the growth of 18.02% The ebitda of Mercury Laboratories Ltd for the Dec '25 is ₹ 2.44 crore as compare to the Sep '25 ebitda of ₹ 2.92 crore. This represent the decline of -16.44% The net profit of Kabra Drugs Ltd changed from ₹ -0.55 crore to ₹ 2.57 crore over 7 quarters. This represents a CAGR of NaN% The net profit of Mercury Laboratories Ltd changed from ₹ 0.34 crore to ₹ 1 crore over 7 quarters. This represents a CAGR of 85.24% The Dividend Payout of Kabra Drugs Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Mercury Laboratories Ltd changed from 7.87 % on March 2021 to 13.38 % on March 2025 . This represents a CAGR of 11.20% over 5 years .

About Kabra Drugs Ltd

Kabra Drugs Limited was incorporated as a Limited Company on August 22, 1989.
The Company has set up a Unit at Indore for manufacturing of Ether derivatives which includes Diethyl Ether (Anesthesia), Solvent Ether, Ethyl Chloride Spray (General Anesthesia) and Surgical.
The commercial production commenced in 1991.
Kabra Drugs Limited is the only manufacturer of Ether derivatives in the State of M.P. tHE Company is presently engaged in the business of Permaculture manufacturing and trading in pharma related products.
The Company has 500+ products across India. The Company was incorporated with a mission to enrich the lives through pharmaceutical solutions which are innovative, high-quality and accessible to every family it serves.

About Mercury Laboratories Ltd

Mercury Laboratories Limited, the registered partnership firm started its business activity in year 1962.
Subsequently, it converted into Private Limited Company & incorporated in February, 1982.
Later, it converted into Limited Company in 1992 in Maharashtra.
The Company has obtained ISO 9001:2008 registrations.
It is engaged into the manufacturing and export of wide range of Pharmaceutical items.

FAQs for the comparison of Kabra Drugs Ltd and Mercury Laboratories Ltd

Which company has a larger market capitalization, Kabra Drugs Ltd or Mercury Laboratories Ltd?

Market cap of Kabra Drugs Ltd is 63 Cr while Market cap of Mercury Laboratories Ltd is 95 Cr

What are the key factors driving the stock performance of Kabra Drugs Ltd and Mercury Laboratories Ltd?

The stock performance of Kabra Drugs Ltd and Mercury Laboratories Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Kabra Drugs Ltd and Mercury Laboratories Ltd?

As of May 9, 2026, the Kabra Drugs Ltd stock price is INR ₹26.85. On the other hand, Mercury Laboratories Ltd stock price is INR ₹799.0.

How do dividend payouts of Kabra Drugs Ltd and Mercury Laboratories Ltd compare?

To compare the dividend payouts of Kabra Drugs Ltd and Mercury Laboratories Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.